DMD Large equally mixed donor pool

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on August 21, 2008; DOI: 10.1124/dmd.108.022731


0090-9556/08/3611-2307-2315$20.00
DMD 36:2307-2315, 2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.108.022731v1
36/11/2307    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Itäaho, K.
Right arrow Articles by Finel, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Itäaho, K.
Right arrow Articles by Finel, M.

The Configuration of the 17-Hydroxy Group Variably Influences the Glucuronidation of β-Estradiol and Epiestradiol by Human UDP-Glucuronosyltransferases

Katriina Itäaho, Peter I. Mackenzie, Shin-ichi Ikushiro, John O. Miners, and Moshe Finel

Division of Pharmaceutical Chemistry (K.I.) and Center for Drug Research (M.F.), Faculty of Pharmacy, University of Helsinki, Helsinki, Finland; Department of Clinical Pharmacology, School of Medicine, Flinders University, Adelaide, South Australia, Australia (P.I.M., J.O.M.); and Department of Biotechnology, Toyama Prefectural University, Toyama, Japan (S.-i.I.)

The glucuronidation of 17β-estradiol (β-estradiol) and 17{alpha}-estradiol (epiestradiol) was studied to elucidate how the orientation of the 17-OH group affects conjugation at the 3-OH or the 17-OH of either diastereomer. Recombinant human UDP-glucuronosyltransferases (UGTs) UGT1A1, UGT1A3, UGT1A7, UGT1A8, and UGT1A10 conjugated one or both diastereomers, mainly at the 3-OH. The activity of UGT1A4 was low and unique because it was directed merely toward the 17-OH of both aglycones. UGT1A10 exhibited particularly high estradiol glucuronidation activity, the rate and affinity of which were significantly higher in the case of β-estradiol than with epiestradiol. UGT1A9 did not catalyze estradiol glucuronidation, but UGT1A9-catalyzed scopoletin glucuronidation was competitively inhibited by β-estradiol. UGT2B4, UGT2B7, and UGT2B17 exclusively conjugated the estradiols at the 17-OH position in a highly stereoselective fashion. UGT2B4 was specific for epiestradiol; UGT2B7 glucuronidated both diastereomers, with high affinity for epiestradiol, whereas UGT2B17 only glucuronidated β-estradiol. UGT2B15 glucuronidated both estradiols at the 3-OH, with a strong preference for epiestradiol. Human UGT2A1 and UGT2A2 glucuronidated both diastereoisomers at both hydroxyl groups. Microsomal studies revealed that human liver mainly yielded epiestradiol 17-O-glucuronide, and human intestine primarily yielded β-estradiol 3-O-glucuronide, whereas rat liver preferentially formed β-estradiol 17-O-glucuronide. Of the three recombinant rat UGTs that were examined in this study, rUGT2B1 was specific for the 17-OH of β-estradiol, rUGT2B2 did not catalyze estradiol glucuronidation, whereas rUGT2B3 exhibited high activity toward the 17-OH in both diastereoisomers. The results show that although many UGTs can catalyze estradiol glucuronidation, there are marked differences in their kinetics, regioselectivity, and stereoselectivity.


Address correspondence to: Moshe Finel, Faculty of Pharmacy, P.O. Box 56 (Viikinkaari 5), University of Helsinki, FIN-00014 Helsinki, Finland. E-mail: moshe.finel{at}helsinki.fi




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
T. Sten, M. Kurkela, T. Kuuranne, A. Leinonen, and M. Finel
UDP-Glucuronosyltransferases in Conjugation of 5{alpha}- and 5{beta}-Androstane Steroids
Drug Metab. Dispos., November 1, 2009; 37(11): 2221 - 2227.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. G. Hu and P. I. Mackenzie
Estrogen Receptor {alpha}, Fos-Related Antigen-2, and c-Jun Coordinately Regulate Human UDP Glucuronosyltransferase 2B15 and 2B17 Expression in Response to 17{beta}-Estradiol in MCF-7 Cells
Mol. Pharmacol., August 1, 2009; 76(2): 425 - 439.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
K. Itaaho, M. H. Court, P. Uutela, R. Kostiainen, A. Radominska-Pandya, and M. Finel
Dopamine Is a Low-Affinity and High-Specificity Substrate for the Human UDP-Glucuronosyltransferase 1A10
Drug Metab. Dispos., April 1, 2009; 37(4): 768 - 775.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
T. Sten, I. Bichlmaier, T. Kuuranne, A. Leinonen, J. Yli-Kauhaluoma, and M. Finel
UDP-Glucuronosyltransferases (UGTs) 2B7 and UGT2B17 Display Converse Specificity in Testosterone and Epitestosterone Glucuronidation, whereas UGT2A1 Conjugates Both Androgens Similarly
Drug Metab. Dispos., February 1, 2009; 37(2): 417 - 423.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. I. Mackenzie, A. Rogers, J. Treloar, B. R. Jorgensen, J. O. Miners, and R. Meech
Identification of UDP Glycosyltransferase 3A1 as a UDP N-Acetylglucosaminyltransferase
J. Biol. Chem., December 26, 2008; 283(52): 36205 - 36210.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
S. Siissalo, H. Zhang, E. Stilgenbauer, A. M. Kaukonen, J. Hirvonen, and M. Finel
The Expression of Most UDP-Glucuronosyltransferases (UGTs) Is Increased Significantly during Caco-2 Cell Differentiation, whereas UGT1A6 Is Highly Expressed Also in Undifferentiated Cells
Drug Metab. Dispos., November 1, 2008; 36(11): 2331 - 2336.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.